All Cancer articles – Page 8
-
BusinessFDA moves to withdraw swine drug carbadox
Carcinogenic antibiotic has been banned in EU, Canada and Australia for years
-
-
BusinessRoche sketches out Blueprint collaboration
Drug discovery startup will contribute to cancer immunotherapy projects aimed at kinase enzymes
-
Business
Lilly loses UK patent challenge
Allergan’s cancer drug generics do not infringe patents, say UK courts
-
ResearchPopping nanobubbles let surgeons sound out micro-tumours
Technique that can hunt down and destroy individual cancer cells is set to get clinical trial
-
NewsObama kicks off new initiative to cure cancer
White House launches ‘moonshot’ effort to fight cancer and break down ‘silos’
-
Business
AstraZeneca to buy Acerta for blood cancer drug
Deal will strengthen AstraZeneca’s immunotherapy offering
-
Business
BioAtla and Pfizer to collaborate on antibody research
Two-way agreement to share technology and royalties on new cancer drugs
-
-
BusinessViral cancer therapy approved in the US
T-Vec is the first approved oncolytic virus, but its limited treatment scope means it is unlikely to become a blockbuster
-
ResearchOral delivery of anticancer drug
Researchers endeavour to limit drug side effects and injections for cancer patients
-
-
Business
BMS agrees $1.7bn immuno-oncology collaboration
Deal strengthens cancer antibody alliance with Five Prime Therapeutics
-
ResearchCheap and sensitive test for a key prostate cancer marker
Supramolecular-coated magnetic beads offer a cheap alternative to current early-stage monitoring techniques
-
Business
Cancer Drugs Fund axes 23 treatments
The UK government has cut down the list of cancer therapies it will pay for through the Cancer Drugs Fund
-
ResearchCancer biomarker counted up with the naked eye
Precise levels of nucleic acids linked to cancer can be detected by the naked eye
-
ResearchSweetening imaging of sugars to study disease
Whole body labelling of zebrafish sugars will provide new insight into cancer, infection and inflammation
-
Business
Grabbing slices of the immuno-oncology pie
Another spate of immuno-oncology dealmaking adds to fervour in pharma’s ‘hottest space’
-
FeaturePharma queues up for checkpoint inhibitor collaborations
Combinations of different firms’ drugs seek to reap immuno-oncology’s benefits
-
ResearchMicrofluidic approach to personalised cancer treatment
Multiple myeloma drug response assay could be adapted for other cancers